Mohammed Tarif Hamza

502 total citations
19 papers, 342 citations indexed

About

Mohammed Tarif Hamza is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mohammed Tarif Hamza has authored 19 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mohammed Tarif Hamza's work include Acute Myeloid Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Neonatal Respiratory Health Research (2 papers). Mohammed Tarif Hamza is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Neonatal Respiratory Health Research (2 papers). Mohammed Tarif Hamza collaborates with scholars based in Egypt, Qatar and Italy. Mohammed Tarif Hamza's co-authors include Gamal Esmat, Ahmed Ihab Abdelaziz, Karim Adel Hosny, Mohamed H. Shahin, Mohamed‐Eslam F. Mohamed, Julie A. Johnson, Noha Mousaad Elemam, Taimour Langaee, Lamiaa N. Hammad and Sherief Khalifa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and FEBS Letters.

In The Last Decade

Mohammed Tarif Hamza

17 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Tarif Hamza Egypt 9 116 98 68 43 42 19 342
Zühal Eroğlu Türkiye 15 192 1.7× 87 0.9× 26 0.4× 57 1.3× 15 0.4× 47 574
Fazhong He China 13 174 1.5× 89 0.9× 64 0.9× 9 0.2× 28 0.7× 38 435
Mingliang Cheng China 11 197 1.7× 78 0.8× 34 0.5× 11 0.3× 67 1.6× 19 482
Hiroaki Yamagami Japan 12 104 0.9× 38 0.4× 52 0.8× 32 0.7× 15 0.4× 44 680
Rame Khasawneh Jordan 13 133 1.1× 53 0.5× 189 2.8× 18 0.4× 19 0.5× 33 451
Sijia Yu China 12 222 1.9× 69 0.7× 22 0.3× 18 0.4× 28 0.7× 40 473
Jun Xue China 9 78 0.7× 27 0.3× 26 0.4× 33 0.8× 33 0.8× 27 322
Sandro Parrotto Italy 6 92 0.8× 78 0.8× 21 0.3× 25 0.6× 28 0.7× 6 355
Kazushige Nirei Japan 12 122 1.1× 42 0.4× 52 0.8× 40 0.9× 13 0.3× 39 685
Hidenari Nagai Japan 14 173 1.5× 78 0.8× 67 1.0× 11 0.3× 75 1.8× 76 649

Countries citing papers authored by Mohammed Tarif Hamza

Since Specialization
Citations

This map shows the geographic impact of Mohammed Tarif Hamza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Tarif Hamza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Tarif Hamza more than expected).

Fields of papers citing papers by Mohammed Tarif Hamza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Tarif Hamza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Tarif Hamza. The network helps show where Mohammed Tarif Hamza may publish in the future.

Co-authorship network of co-authors of Mohammed Tarif Hamza

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Tarif Hamza. A scholar is included among the top collaborators of Mohammed Tarif Hamza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Tarif Hamza. Mohammed Tarif Hamza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hamza, Mohammed Tarif, et al.. (2023). Factor V Leiden (FVL), Prothrombin G20210A and MTHFR C677T Mutations among Patients of Budd-Chiari Syndrome. QJM. 116(Supplement_1). 1 indexed citations
2.
Nassar, May Fouad, et al.. (2021). Effect of ketogenic diet for drug-resistant epilepsy on immunological cells. Neurological Sciences. 43(3). 1987–1992. 5 indexed citations
3.
Eid, Maha M., et al.. (2020). Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations. Current Pharmaceutical Biotechnology. 21(13). 1394–1401. 3 indexed citations
4.
5.
Elemam, Noha Mousaad, R.A. Youness, Mohammad Elsayed, et al.. (2019). Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models. Archives of Virology. 164(6). 1587–1595. 35 indexed citations
6.
Eid, Maha M., et al.. (2019). Telomerase reverse transcriptase gene amplification in hematological malignancies. SHILAP Revista de lepidopterología. 20(1). 2 indexed citations
8.
Hamza, Mohammed Tarif, et al.. (2017). Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome. Journal of Neonatal-Perinatal Medicine. 10(1). 79–83. 10 indexed citations
9.
Elmiligi, Haytham, Mohammed Tarif Hamza, & M. Watheq El‐Kharashi. (2017). A power-optimized, area-efficient implementation of Connection-Then-Credit NoC physical layer. Microelectronics Journal. 68. 55–68. 1 indexed citations
10.
Pecci, Alessandro, Iman Ragab, Valeria Bozzi, et al.. (2017). Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim. EMBO Molecular Medicine. 10(1). 63–75. 41 indexed citations
11.
Hamza, Mohammed Tarif, et al.. (2016). Sustained versus intermittent lung inflation for resuscitation of preterm infants: a randomized controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine. 30(11). 1273–1278. 24 indexed citations
12.
Hamza, Mohammed Tarif, et al.. (2016). Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth. Growth Factors. 34(1-2). 42–50. 35 indexed citations
13.
Hamza, Mohammed Tarif, et al.. (2015). miR‐1275: A single microRNA that targets the three IGF2‐mRNA‐binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Letters. 589(17). 2257–2265. 55 indexed citations
14.
Hamza, Mohammed Tarif, et al.. (2014). Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor. Journal of Infection. 70(1). 78–87. 26 indexed citations
15.
Reda, Shereen M., et al.. (2014). Could recurrent otitis media predict primary antibody deficiencies in Egyptian children?. The Egyptian Journal of Otolaryngology. 30(2). 82–87. 1 indexed citations
16.
Hamza, Mohammed Tarif & Hazem Khamis. (2014). Renal Sympathetic Denervation for Treatment of Resistant Hypertension: Egyptian Experience. Journal of Interventional Cardiology. 27(4). 423–427. 5 indexed citations
17.
Tantawy, Azza Abdel Gawad, et al.. (2012). Pathogenesis and Prognosis of Neutropenia in Infants and Children Admitted in a University Children Hospital in Egypt. Pediatric Hematology and Oncology. 30(1). 51–59. 8 indexed citations
18.
Shahin, Mohamed H., Sherief Khalifa, Yan Gong, et al.. (2011). Genetic and nongenetic factors associated with warfarin doserequirements in Egyptian patients. Pharmacogenetics and Genomics. 21(3). 130–135. 75 indexed citations
19.
Hamza, Mohammed Tarif, et al.. (1996). HLA AND LEPROSY: SEGREGATION AND LINKAGE STUDY. International Journal of Dermatology. 35(4). 257–264. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026